Health economics at the crossroads of centuries – From the past to the future

Frontiers in Public Health

Volumn 4, Issue , 2016, Pages

  Jakovljevic, Mihajlo Michael ^a   Ogura, Seiritsu ^b  

^a University of Kragujevac Medical Faculty   (Serbia)

^b HOSEI UNIVERSITY   (Japan)

Author keywords

Bibliograph; Future; Health economics; Health policy; Health systems; History; Twenty first century

Indexed keywords

EID: 84983532370     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2016.00115     Document Type: Article

References (64)

1. Rebelo LP. The Origins and the Evolution of Health Economics: A Discipline by Itself ? (2007). Available from: https://ideas.repec.org/p/cap/wpaper/162007.html
2. Friedman M. Professor Pigou’s method for measuring elasticities of demand from budgetary data. Q J Econ (1935) 50(1):151–63. doi:10.2307/1882346
3. Friedman M, Kuznets S. Income from Independent Professional Practice. Chicago: NBER Books (1954).
4. Mushkin SJ. Toward a definition of health economics. Public Health Rep (1958) 73(9):785. doi:10.2307/4590242
5. Mushkin SJ. Health as an investment. J Polit Econ (1962) 70:129–57. doi:10.1086/258730
6. Arrow KJ. Uncertainty and the welfare economics of medical care. Am Econ Rev (1963) 53(5):941–73.
7. Grossman M. On the concept of health capital and the demand for health. J Polit Econ (1972) 80(2):223–55. doi:10.1086/259880
8. Grossman M. The demand for health, 30 years later: a very personal retrospective and prospective reflection. J Health Econ (2004) 23(4):629–36. doi:10.1016/j.jhealeco.2004.04.001
9. Grossman M. ‘A theory of the allocation of time’ turns fifty: its impact on the field of health economics. Health Econ (2016) 25(1):3–7. doi:10.1002/hec.3265
10. Fuchs VR. Who Shall Live? Health, Economics, and Social Choices. New York: Basic Books (1972).
11. Wagstaff A, Culyer AJ. Four decades of health economics through a bibliometric lens. J Health Econ (2012) 31:406–39. doi:10.1016/j.jhealeco.2012. 03.002
12. Arai Y, Ikegami N. Health care systems in transition II. Japan, part I. An overview of the Japanese health care systems. J Public Health Med (1998) 20:29–33. doi:10.1093/oxfordjournals.pubmed.a024713
13. Cumming J. Health economics and health policy: experiences from New Zealand. Appl Health Econ Health Policy (2015) 13:281–9. doi:10.1007/s40258-014-0149-y
14. Jakovljevic MB. Resource allocation strategies in Southeastern European health policy. Eur J Health Econ (2013) 14(2):153–9. doi:10.1007/s10198-012-0439-y
15. Blumenschein K, Johannesson M. Economic evaluation in healthcare. A brief history and future directions. Pharmacoeconomics (1996) 10(2):114–22. doi:10.2165/00019053-199610020-00003
16. Yoshikawa A, Bhattacharya J, Vogt WB, editors. Health Economics of Japan: Patients, Doctors, and Hospitals Under a Universal Health Insurance System. Tokyo: University of Tokyo Press (1996).
17. McGuire A, Henderson J, Mooney G. The Economics of Health Care: An Introductory Text. New York: Routledge & Kegan Paul (1988).
18. Health Economics Textbooks. (2016). Available from: https://www.bookdepository.com/category/950/Health-Economics
19. Anderson GF, Frogner BK, Johns RA, Reinhardt UE. Health care spending and use of information technology in OECD countries. Health Aff (2006) 25(3):819–31. doi:10.1377/hlthaff.25.3.819
20. OECD. Health care systems: getting more value for money. OECD Economics Department Policy Notes, No. 2. (2010). Available at: https://www.oecd.org/eco/growth/46508904.pdf
21. Jakovljevic M. Comparison of historical medical spending patterns among the BRICS and G7. J Med Econ (2016) 19(1):70–6. doi:10.3111/13696998.2 015.1093493
22. Jakovljevic MB. BRIC’s growing share of global health spending and their diverging pathways. Front Public Health (2015) 3:135. doi:10.3389/fpubh.2015.00135
23. Wagstaff A, Culyer AJ. Four Decades of Health Economics through a Bibliometric Lens. Washington, DC: The World Bank, Development Research Group, Human Development and Public Services Team (2011).
24. Jack W. Principles of Health Economics for Developing Countries. Washington, DC: World Bank Publications (1999).
25. Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. JAMA (2009) 302(13):1437–43. doi:10.1001/jama.2009.1409
26. Privatization of The Canadian Health Care System Not yet and Hopefully Never. (2016). Available from: https://www.uow.edu.au/~bmartin/dissent/documents/health/privat_canada.html
27. Brockis E, Marsden G, Cole A, Devlin N. A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications Research Paper. Office of Health Economics, National Clinical Guidelines Centre, Royal College of Physicians (2016).
28. Carroll S, Carroll R. Why health economics is becoming ever more important in the industry. Pharm J (2009) 282(7542):255.
29. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med (1977) 296(13):716–21. doi:10.1056/NEJM197703312961304
30. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA (1992) 268(17):2420. doi:10.1001/jama.1992.03490170092032
31. The archive of the old Cochrane Community website Cochrane Database of Systematic Reviews (CDSR). (2016). Available from: http://communityarchi ve. cochr ane. org/edi t or i al-and-publ i s hi ng-pol i c y-res ource/cochrane-database-systematic-reviews-cdsr
32. The National Institute for Health and Care Excellence. (2016). Available from: https://www.nice.org.uk/
33. Jennett B. Health technology assessment. BMJ (1992) 305(6845):67–8. doi:10.1136/bmj.305.6845.67
34. The International Network of Agencies for Health Technology Assessment. (2016). Available from: http://www.inahta.org/our-members/members/
35. Non-Aligned Movement History. (2001). Available from: http://www.nam.gov. za/background/history.htm
36. Ehrlich PR, Ehrlich AH. The Population Explosion. Information Provided by the Authority of Non-Aligned Movement. Content Hosted by the Government of South Africa. New York: Simon and Schuster (1990).
37. Hatton TJ, Williamson JG. Global Migration and the World Economy: Two Centuries of Policy and Performance. Cambridge: MIT Press (2005). 290 p.
38. Harford J, Ogura S. Pollution taxes and standards: a continuum of quasi-optimal solutions. J Environ Econ Manage (1983) 10(1):1–17. doi:10.1016/0095-0696(83)90011-6
39. Haines A. Global warming and health. BMJ (1991) 302(6778):669–70. doi:10.1136/bmj.302.6778.669
40. Jakovljevic M, Vukovic M, Fontanesi J. Life expectancy and health expenditure evolution in Eastern Europe-DiD and DEA analysis. Expert Rev Pharmacoecon Outcomes Res (2015) 17:1–10. doi:10.1586/14737167.2016. 1125293
41. Bärnighausen T, Sauerborn R. One hundred and eighteen years of the German health insurance system: are there any lessons for middle-and low-income countries? Soc Sci Med (2002) 54(10):1559–87. doi:10.1016/S0277-9536(01)00137-X
42. Jakovljevic M, Getzen T. Growth of global health spending share in low and middle income countries. Front Pharmacol (2016) 7:21. doi:10.3389/fphar.2016.00021
43. Jakovljevic M. The key role of leading emerging BRIC markets for the future of global health care. Serb J Exp Clin Res (2014) 15(3):139–43. doi:10.5937/sjecr1403139J
44. Jakovljevic M, et al. Health Economics and Policy Challenges in Global Emerging Markets. New York City: Nova Science Publishers (2016).
45. Hu S, Tang S, Liu Y, Zhao Y, Escobar ML, De Ferranti D. Reform of how health care is paid for in China: challenges and opportunities. Lancet (2008) 372(9652):1846–53. doi:10.1016/S0140-6736(08)61368-9
46. Jakovljevic M, Groot W, Souliotis K. Health care financing and affordability in the emerging global markets. Front Public Health (2016) 4:2. doi:10.3389/fpubh.2016.00002
47. Jakovljevic M. The aging of Europe. The unexplored potential. Farmeconomia Health Econ Ther Pathw (2015) 16(4):89–92. doi:10.7175/fe.v16i4.1220
48. Jakovljevic M, Laaser U. Population aging from 1950 to 2010 in seventeen transitional countries in the wider region of South Eastern Europe (original research). SEEJPH (2015). doi:10.12908/SEEJPH-2014-42
49. Ogura S. The cost of aging: public finance perspectives for Japan. In: Noguchi Y, Wise D, editors. Aging in the United States and Japan: Economic Trends. Chicago: University of Chicago Press (1994). p. 139–74.
50. Ogura S, Tachibanaki T, Wise DA, editors. Aging Issues in the United States and Japan. Chicago: University of Chicago Press (2007).
51. Chen S, Powell JL, editors. Aging in China: Implications to Social Policy of a Changing Economic State. Vol. 2. New York: Springer Science & Business Media (2012).
52. Yount KM, Sibai AM. Demography of aging in Arab countries. In: Uhlenberg P, editor. International Handbook of Population Aging. Netherlands: Springer (2009). p. 277–315.
53. Soy NH. Ageing in Developing Countries: Population Projections and Policy Making in Turkey. (2012). Available from: http://www.kuasu.cpier.kyoto-u. ac.jp/wp-content/uploads/2015/10/Nesibe-Hicret-Soy.pdf
54. UCSF Global Health Sciences. (2015). Available from: http://globalhealthsciences.ucsf.edu/research/global-health-economics-consortium-ghecon/funding-opportunities
55. National Institutes of Health. Funding Opportunities. (2013). Available from: https://commonfund.nih.gov/healtheconomics/grants
56. Public Health Economics. Funding Opportunities in Public Health Economics Research. (2015). Available from: http://publichealtheconomics.org/fundingopportunities-in-public-health-economics-research/
57. National Institutes of Health. Wolinetz C. NOT-OD-16-025-Clarifying NIH Priorities for Health Economics Research. (2015). Available from: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-025.html
58. Sevilla JP. Value pricing by developing countries and its impact on allocative and dynamic efficiency in the global pharmaceutical industry. J Law Econ Policy (2015) 12(2).
59. Yang W. How does the pharmaceutical industry influence prescription? A qualitative study of provider payment incentives and drug remunerations in hospitals in Shanghai. Health Econ Policy Law (2016) 26:1–17. doi:10.1017/S1744133116000086
60. Blomqvist ÅG, Carter RA. Is health care really a luxury? J Health Econ (1997) 16(2):207–29. doi:10.1016/S0167-6296(96)00534-6
61. Wagstaff A, Van Doorslaer E. Equity in health care finance and delivery. Handb Health Econ (2000) 1:1803–62. doi:10.1016/S1574-0064(00)80047-5
62. McIntyre DI, Thiede M, Birch S. Access as a policy-relevant concept in lowand middle-income countries. Health Econ Policy Law (2009) 4(02):179–93. doi:10.1017/S1744133109004836
63. Lagomarsino G, Garabrant A, Adyas A, Muga R, Otoo N. Moving towards universal health coverage: health insurance reforms in nine developing countries in Africa and Asia. Lancet (2012) 380(9845):933–43. doi:10.1016/S0140-6736(12)61147-7
64. Ashmore M, Mulkay MJ, Pinch TJ. Health and Efficiency: A Sociology of Health Economics. Milton Keynes: Open University (1989).